The possible role of Cytochrome c and programmed cell death protein 4 (PDCD4) on pathogenesis of hepatocellular carcinoma
Keywords: HCC; Apoptosis; HCC; PCDC4; Cytochrome c
مقالات ISI HCC (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Involvement of zebrafish RIG-I in NF-κB and IFN signaling pathways: Insights into functional conservation of RIG-I in antiviral innate immunity
Keywords: HCC; RIG-I; retinoic acid-inducible gene I; PRRs; pattern recognition receptors; IFN-I; type I IFN; TLRs; toll-like receptors; RLRs; retinoic acid-inducible gene I (RIG-I)-like receptors; MDA5; melanoma differentiation associated factor 5; LGP2; laboratory of
High-dose cyclophosphamide induces specific tumor immunity with concomitant recruitment of LAMP1/CD107a-expressing CD4-positive T cells into tumor sites
Keywords: HCC; CC chemokine; CD4+ T cell; Cytolytic T cell; LAMP1/CD107a; APC; allophycocyanin; CFSE; carboxyfluorescein diacetate, succinimidyl ester; CTLs; cytolytic T lymphocytes; CTX; cyclophosphamide; dLN; draining lymph node; FCM; flow cytometry; FITC; fluorescein
Development and evaluation of analytical performance of a fully automated chemiluminescent immunoassay for protein induced by vitamin K absence or antagonist II
Keywords: HCC; PIVKA-II; Protein induced by vitamin K absence or antagonist II; HCC; hepatocellular cancer; LoB; limit of blank; LoD; limit of detection; LoQ; limit of quantitation; %CV; percentage coefficient of variation; HBV; hepatitis B virus; HCV; hepatitis C virus
Research ArticlePerformance of PIVKA-II for early hepatocellular carcinoma diagnosis and prediction of microvascular invasion
Keywords: HCC; HCC; hepatocellular carcinoma; US; ultrasonography; AFP; α-fetoprotein; PIVKA-II; prothrombin induced by vitamin K absence-II; MVI; microvascular invasion; LR; liver resection; LT; liver transplantation; BCLC; Barcelona Clinic Liver Cancer; CLD; chronic
Research ArticleStatin use and the risk of cirrhosis development in patients with hepatitis C virus infection
Keywords: HCC; HCV; hepatitis C virus; HCC; hepatocellular carcinoma; HALT-C; Hepatitis C Antiviral Long-term Treatment Against Cirrhosis; NHIRD; National Health Insurance Research Database; ICD-9 codes; International Classification of Diseases, Ninth Revision codes; DD
New techniques of H1 spectroscopy on the liver: Reworking of NMR sequences
Keywords: HCC; Liver; H1 spectroscopy; PRESS SV sequence; STEAM SV sequence; MRS; FT-NMR; EPIC; Environment For Pulse Programming in C; FID; free induction decay; FT; Fourier transform; HCC; hepatocellular carcinoma; MRS; magnetic resonance spectroscopy; NMR; nuclear ma
Siglec-10 is associated with survival and natural killer cell dysfunction in hepatocellular carcinoma
Keywords: HCC; CD24; Siglec-10; HCC
Validation of the Concept of a Common Typical Time of Disease Duration for Hepatocellular Carcinoma Patients Using the Fisher Information Processing of Tumor Imaging Results Combined With Network Phenotyping Strategy Quantification of Individual Patient C
Keywords: HCC; HCC; hepatocellular carcinoma; Tmass; product of the number of tumor nodules and the maximal diameter of the tumor; ln(Tmass); natural logarithm of tumor mass; ln(Tmass); natural logarithm of the probability density Ï of finding given Tmass; Tonset; time
Mitochondrial iron accumulation exacerbates hepatic toxicity caused by hepatitis C virus core protein
Keywords: HCC; HCV; hepatitis C virus; HCC; hepatocellular carcinoma; ROS; reactive oxygen species; Fe-NTA; ferric nitrilacetic acid; JC-1; 5,5â²,6,6â²-tetrachrolo-1,1â²,3,3â²-tetraethylbenzimidazoly-carbocyanine iodide; CCCP; carbonyl cyanide-m-chlorophenyl hydrazi
Transarterial Hepatic Chemoembolization with 70-150 µm Drug-Eluting Beads: Assessment of Clinical Safety and Liver Toxicity Profile
Keywords: HCC; AE; adverse event; DEB; drug-eluting bead; HCC; hepatocellular carcinoma; LBI; liver/biliary injuries; PES; postembolization syndrome;
Antibody mediated therapy targeting CD47 inhibits tumor progression of hepatocellular carcinoma
Keywords: HCC; CD47; HCC; Antibody therapy; Xenograft models; CD47mAb400; CD47 monoclonal antibody (Clone 400); CFSE; carboxy fluorescein diacetate succinimidyl ester; H3B; Hep3B; HCC; hepatocelluar carcinoma; MTT; 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium br
ReviewBioinformatics and database resources in hepatology
Keywords: HCC; Bioinformatics; Computational biology; Database; Genetics; Proteomics; HBV; HCV; Viral hepatitis; NASH; NAFLD; HCC; Toxic liver disease;
Research ArticleHypoxia induced HMGB1 and mitochondrial DNA interactions mediate tumor growth in hepatocellular carcinoma through Toll-like receptor 9
Keywords: HCC; HCC; hepatocellular carcinoma; DAMPs; damage associated molecular patterns; HMGB1; High mobility group box-1; mtDNA; Mitochondrial Deoxyribonucleic acid; TLR; toll-like receptor; DMEM; Dulbecco's Modified Eagle's Medium; shRNA; short hairpin ribonucle
Research ArticleHepatitis C viral proteins perturb metabolic liver zonation
Keywords: HCC; HCV; hepatitis C virus; HCC; hepatocellular carcinoma; PP; periportal; PV; perivenous; FASN; fatty acid synthase; ACSL3; acyl-CoA synthetase long-chain family member 3; SCD1; stearoyl-CoA desaturase; GS; glutamine synthetase; HCV; Metabolic liver zonation
Research ArticleIncidence and predictors of hepatocellular carcinoma in Caucasian chronic hepatitis B patients receiving entecavir or tenofovir
Keywords: HCC; HCC; hepatocellular carcinoma; CHB; chronic hepatitis B; ETV; entecavir; TDF; tenofovir; HBV; hepatitis B virus; NAs; nucleos(t)ide analogues; ALT; alanine aminotransferase; SD; standard deviation; IQR; interquartile range; HR; hazard ratio; CI; confidenc
Research ArticleComplete response of Ctnnb1-mutated tumours to β-catenin suppression by locked nucleic acid antisense in a mouse hepatocarcinogenesis model
Keywords: HCC; HCC; hepatocellular cancer; LNA; locked nucleic acid; DEN/PB; diethylnitrosamine and phenobarbital; GSK-3β; glycogen synthase kinase-3β; APC; Adenomatous polyposis coli; Fzd; Frizzled; LRP; low-density lipoprotein receptor related protein; CREB; cAMP re
Research ArticleIs antenatal screening for hepatitis C virus cost-effective? A decade's experience at a London centre
Keywords: HCC; HCV; hepatitis C virus; ESLD; end stage liver disease; HCC; hepatocellular carcinoma; DAA; direct acting antiviral; HBV; hepatitis B virus; REDCAP; research electronic data capture; MONARCH; modelling the natural history and cost-effectiveness of hepatiti
Research ArticleQuantification of HBsAg in nucleos(t)ide-naïve patients treated for chronic hepatitis B with entecavir with or without tenofovir in the BE-LOW study
Keywords: HCC; CHB; chronic hepatitis B; HBV; hepatitis B virus; HCC; hepatocellular carcinoma; cccDNA; covalently closed circular DNA; HBsAg; hepatitis B surface antigen; peg-IFN; pegylated interferon; HBeAg; hepatitis B e antigen; ETV; entecavir; TDF; tenofovir disopr
Research ArticleRegular exercise decreases liver tumors development in hepatocyte-specific PTEN-deficient mice independently of steatosis
Keywords: HCC; HCC; hepatocellular carcinoma; NAFLD; non-alcoholic fatty liver disease; NASH; non-alcoholic steatohepatitis; PTEN; phosphatase and tensin homolog deleted from chromosome 10; NAS; NAFLD activity score; qPCR; Real-Time Quantitative Polymerase Chain Reactio
GGPPS deficiency aggravates CCl4-induced liver injury by inducing hepatocyte apoptosis
Keywords: HCC; GGPPS; geranylgeranyl diphosphate synthase; GGPP; geranylgeranyl pyrophosphate; HMG-CoA; 3-hydroxy-3-methylglutarylcoenzyme A; CCl4; carbon tetrachloride; ECM; extracellular matrix; COL1A1; type I collagen; HCV; hepatitis C virus; NASH; non-alcoholic stea
Respiratory complexes III and IV can each bind two molecules of cytochrome c at low ionic strength
Keywords: HCC; CSP; Chemical-Shift Perturbations; Cbc1; cytochrome bc1; Cc; cytochrome c; CcO; cytochrome c oxidase; Cc1; cytochrome c1; (III); complex III; (IV); complex IV; DLS; dynamic light scattering; ET; electron transfer; KD; equilibrium dissociation constant; HS
De novo hepatocellular carcinoma of liver allograft: A neglected issue
Keywords: HCC; CNI; calcineurin-inibitors; FISH; fluorescent in situ hybridization; HBV; hepatitis B virus; HCC; hepatocellular carcinoma; HCV; hepatitis C virus; MMF; mycophenolate mofetil; mTOR; target of rapamycin; OLT; orthotopic liver transplant; PCR; polymerase ch
Mutations leading to constitutive active gp130/JAK1/STAT3 pathway
Keywords: HCC; Inflammatory hepatocellular adenomas; gp130; STAT3; FRK; GNAS; JAK1; HCA; hepatocellular adenoma; IHCA; inflammatory HCA; HCC; hepatocellular carcinoma; STATs; ignal transducer and activator of transcription; JAK; Janus kinase; LGL; large granular lymphoc
Heat shock protein 20 (HSPB6) regulates TNF-α-induced intracellular signaling pathway in human hepatocellular carcinoma cells
Keywords: HCC; HSP20; TNF-α; HCC; IKK-α; Cell proliferation
Permethylated Anigopreissin A inhibits human hepatoma cell proliferation by mitochondria-induced apoptosis
Keywords: HCC; PAA; Permethylated Anigopreissin A; HCC; hepatocellular carcinoma; MMP; mitochondrial membrane potential; DAPI; 4â²,6-diamidino-2-phenylindole; PI; propidium iodide; MTT; 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; CDKs; cyclin-dependen
Therapy Response Assessment after Radioembolization of Patients with Hepatocellular Carcinoma-Comparison of MR Imaging with Gadolinium Ethoxybenzyl Diethylenetriamine Penta-Acetic Acid and Gadobutrol
Keywords: HCC; AUC; area under the curve; FOV; field of view; Gd-EOB-DTPA; gadolinium ethoxybenzyl diethylenetriamine penta-acetic acid; HCC; hepatocellular carcinoma; TE; echo time; TR; repetition time;
Research ArticleSorafenib inhibits macrophage-induced growth of hepatoma cells by interference with insulin-like growth factor-1 secretion
Keywords: HCC; HCC; hepatocellular carcinoma; TAM; tumor associated macrophages; M1; classical polarized macrophages; M2; alternative polarized macrophages; EGF; epidermal growth factor; VEGF; vascular endothelial growth factor; IGF-1; insulin-like growth factor-1; TKI;
Research ArticleRetreatment with TACE: The ABCR SCORE, an aid to the decision-making process
Keywords: HCC; HCC; Chemoembolization; BCLC; Radiological response; ABCR score; ART score; TACE;
Low serum interleukin-6 levels as a predictive marker of recurrence in patients with hepatitis B virus related hepatocellular carcinoma who underwent curative treatment
Keywords: HCC; AFP; alpha-fetoprotein; CI; confidence interval; CT; computed tomography; DFS; disease-free survival; EGF; epidermal growth factor; FGF-2; fibroblast growth factor-2; G-CSF; granulocyte colony-stimulating factor; HBV; hepatitis B virus; HCC; hepatocellula
A Single-Center Retrospective Comparison of Doxorubicin-Loaded HepaSphere Transarterial Chemoembolization with Conventional Transarterial Chemoembolization for Patients with Unresectable Hepatocellular Carcinoma
Keywords: HCC; AST; aspartate aminotransferase; BCLC; Barcelona Clinic Liver Cancer; DEE; drug-eluting embolic; HCC; hepatocellular carcinoma;
Non-coding RNAs in gastric cancer
Keywords: HCC; ncRNAs; non-coding RNAs; sncRNAs; small ncRNAs; lncRNAs; long ncRNAs; snoRNAs; small nucleolar RNAs; piRNAs; Piwi-associated RNAs; miRNAs; microRNAs; tiRNAs; transcription initiation RNAs; lincRNAs; long intergenic ncRNAs; GC; gastric cancer; nts; nucleot
Research ArticleHepatitis C virus-mediated Aurora B kinase inhibition modulates inflammatory pathway and viral infectivity
Keywords: HCC; HCV; hepatitis C virus; HCC; hepatocellular carcinoma; AURKB; Aurora B kinase; PP2; protein phosphatase 2; Chk1; checkpoint kinase 1; NF-κB; nuclear factor-κB; COX-2; cyclooxygenase-2; Hepatitis C; Inflammation; NF-κB; COX-2; Histone modifications;
Naturally occurring deletion/insertion mutations within HBV whole genome sequences in HBeAg-positive chronic hepatitis B patients are correlated with baseline serum HBsAg and HBeAg levels and might predict a shorter interval to HBeAg loss and seroconversi
Keywords: HCC; aa; amino acid; ADV; adefovir dipivoxil; anti-HBe; antibodies to hepatitis B e antigen; BCP; basic core promoter; C; core; CHB; chronic hepatitis B; CP; core promoter; Del/Ins; deletion/insertion; DR; direct repeat; EN; enhancer; S; surface; HBeAg; hepati
Research ArticleStatin and the risk of hepatocellular carcinoma and death in a hospital-based hepatitis B-infected population: A propensity score landmark analysis
Keywords: HCC; HBV; hepatitis B virus; HCC; hepatocellular carcinoma; NA; nucleos(t)ide analogue; HMG-CoA; 3-hydroxy-3-methylglutaryl CoA; DDD; daily defined doses; HR; hazard ratio; CI; confidence interval; HA; Hospital Authority; HCV; hepatitis C virus; HIV; human imm
A novel baseline hepatitis B virus sequencing-based strategy for predicting adefovir antiviral response
Keywords: HCC; ADV; adefovir dipivoxil; ALT; alanine aminotransferase; AST; aspartic aminotransferase; AUC; area under the curve; BMI; body mass index; CHB; chronic hepatitis B; ETV; entecavir; HBV; hepatitis B virus; HCV; hepatitis C virus; HDV; hepatitis D virus; HCC;
Research ArticleThe long-term benefits of nucleos(t)ide analogs in compensated HBV cirrhotic patients with no or small esophageal varices: A 12-year prospective cohort study
Keywords: HCC; EV; esophageal varices; NUC; nucleos(t)ide analogs; GI; gastrointestinal; LMV; lamivudine; LMV-R; lamivudine resistance; HCC; hepatocellular carcinoma; HBV; hepatitis B virus; HVPG; hepatic venous pressure gradient; EGDS; esophago-gastroduodenoscopy; PHG;
Research ArticleDefeating EpCAM+ liver cancer stem cells by targeting chromatin remodeling enzyme CHD4 in human hepatocellular carcinoma
Keywords: HCC; AFP; alpha-fetoprotein; CHD; chromodomain-helicase-DNA-binding proteins; CSC; cancer stem cell; DSBs; double strand breaks; EpCAM; epithelial cell adhesion molecule; HCC; hepatocellular carcinoma; HDAC; histone deacetylase; HpSC; hepatic stem cell-like; N
Original ResearchFull Report: Clinical-LiverSofosbuvir and Ribavirin Prevent Recurrence of HCV Infection After Liver Transplantation: An Open-Label Study
Keywords: HCC; Hepatitis C Virus; Liver Transplantation; HCV Recurrence; Direct-Acting Antiviral Agents; HCC; hepatocellular carcinoma; HCV; hepatitis C virus; LLOQ; lower limit of quantification; MELD; model for end-stage liver disease; pTVR; post-transplantation virol
Andrographolide decreased VEGFD expression in hepatoma cancer cells by inducing ubiquitin/proteasome-mediated cFos protein degradation
Keywords: HCC; Andro; Andrographolide; VEGFD; Vascular endothelial growth factor D; ELISA; Enzyme-linked immunosorbent assay; AP-1; Activator protein-1; JNK; c-Jun N-terminal kinase; MAPK; Mitogen-activated protein kinase; VEGF; Vascular endothelial growth factor; MMP2;
The role of AGR2 and AGR3 in cancer: Similar but not identical
Keywords: HCC; AGR2; AGR3; PDI family; Cancer; AA; amino acids; ALS; familial amyotrophic lateral sclerosis; AGR; anterior gradient; AhR; aryl hydrocarbon receptor; AR; androgen receptor; CAPN8; calpain 8; CAPN9; calpain 9; CDDP; cisplatin; CFTR; cystic fibrosis transme
Idarubicin-Loaded ONCOZENE Drug-Eluting Embolic Agents for Chemoembolization of Hepatocellular Carcinoma: In Vitro Loading and Release and In Vivo Pharmacokinetics
Keywords: HCC; AE; adverse event; AUC0-24 h; area under the concentration-time curve from 0-24 hours; Cmax; maximum concentration; DEE; drug-eluting embolic; HCC; hepatocellular carcinoma; LLOQ; lower limit of quantification; MDR; multidrug resistance; PK; pharmacok
ReviewTrends in the management and burden of alcoholic liver disease
Keywords: HCC; AH; alcoholic hepatitis; ALD; Alcoholic liver disease; ASH; alcoholic steatohepatitis; DF; discriminant function; HCC; hepatocellular carcinoma; LPS; lipopolysaccharide; NIAAA; National Institute on Alcohol Abuse and Alcoholism; Burden of alcoholic liver
Research ArticleGas6/Axl pathway is activated in chronic liver disease and its targeting reduces fibrosis via hepatic stellate cell inactivation
Keywords: HCC; ALD; alcoholic liver disease; COL1A1; Collagen 1A1; ECM; extracellular matrix; HCC; hepatocellular carcinoma; HCV; hepatitis C virus; HSCs; hepatic stellate cells; MMP; matrix metalloproteinase; PCNA; proliferating cell nuclear antigen; ProS; Protein S; r
Research ArticleSerum-based tracking of de novo initiated liver cancer progression reveals early immunoregulation and response to therapy
Keywords: HCC; SBT; Sleeping Beauty Transposition; GLuc; Gaussia Luciferase expression SBT vector; HCC; hepatocellular carcinoma; HCA; hepatocellular adenoma; GLuc+ hepatocytes; GLuc vector integrated in hepatocytes; HSB2; Sleeping Beauty transposase; MET; human c-Met;
Research ArticleTRIM24 suppresses development of spontaneous hepatic lipid accumulation and hepatocellular carcinoma in mice
Keywords: HCC; TRIM; tripartite motif protein; HCC; hepatocellular carcinoma; LoxP; locus of crossover in P1; Zp3; zona pellucida 3; ChIP; chromatin immunoprecipitation; NAFLD; non-alcoholic fatty liver disease; TG; triglycerides; NASH; non-alcoholic steatohepatitis; IF
Research ArticleThe oral toll-like receptor-7 agonist GS-9620 in patients with chronic hepatitis B virus infection
Keywords: HCC; CHB; Chronic hepatitis B; AUC; Area under the curve; DMC; Data monitoring committee; GALT; Gut-associated lymphoid tissue; HBV; Hepatitis B virus; HCV; Hepatitis C virus; HCC; Hepatocellular carcinoma; ISG; Interferon-stimulated genes; MAD; Multiple-ascen
Research ArticleLiver resection for hepatocellular carcinoma in patients with metabolic syndrome: A multicenter matched analysis with HCV-related HCC
Keywords: HCC; HCC; Hepatocellular carcinoma; NAFLD; non-alcoholic fatty liver disease; NASH; non-alcoholic steatohepatitis; MS; metabolic syndrome; LR; liver resection; BMI; body mass index; CT; computed tomography; ICG; indocyanine green retention; FLR; future liver r
Research ArticleDisruption of a regulatory loop between DUSP1 and p53 contributes to hepatocellular carcinoma development and progression
Keywords: HCC; AJCC; American Joint Committee on Cancer; a.a.; amino acid; CKS1; CDC28 protein kinase b1; DNA-BD; DNA-binding domain; Dox; doxorubicin; DUSP1; dual specificity phosphatase 1; FACS; fluorescence-activated cell sorting; GEO; gene expression omnibus; HCC; h
Research ArticleSustained efficacy and seroconversion with the Toll-like receptor 7 agonist GS-9620 in the Woodchuck model of chronic hepatitis B
Keywords: HCC; CHB; chronic hepatitis B; TLR7; toll-like receptor 7; WHV; woodchuck hepatitis virus; HBV; hepatitis B virus; WHsAg; WHV surface antigen; HCC; hepatocellular carcinoma; IFN-α; interferon-alpha; HBsAg; hepatitis B surface antigen; HBsAb; anti-HBs antibody